Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02651662
Title Study of REGN2810 and REGN1979 in Patients With Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Regeneron Pharmaceuticals
Indications

Hodgkin's lymphoma

non-Hodgkin lymphoma

Therapies

Cemiplimab

Cemiplimab + Odronextamab

Age Groups: adult | senior
Covered Countries USA | ESP | DEU


No variant requirements are available.